Rasmus Rabøl

Rasmus Rabøl is the Chief Medical Officer, EVP, and Head of Advisory at KLIFO A/S, bringing a robust clinical and research background in diabetes and metabolism. They hold an MD and PhD, with extensive experience in drug development from their tenure at Novo Nordisk, where they led significant projects including Cardiovascular Outcomes Trials and held various leadership roles. Rasmus also has regulatory experience from the Danish Medicines Agency and completed their medical training at the University of Copenhagen. Currently, they focus on translational science and early clinical testing to enhance drug development strategies.